Veracyte Inc
Company Overview
Veracyte, Inc. is a global diagnostics company that provides genomic testing solutions for early and accurate diagnosis of cancer and other diseases. The company uses advanced genomic technology and machine learning algorithms to help improve patient care and reduce unnecessary surgeries.
Their main products include genomic tests for thyroid cancer (Afirma), lung cancer (Percepta), breast cancer (Prosigna), and other diagnostic solutions. The company's business model is based on developing and commercializing laboratory-developed tests that help physicians make more informed treatment decisions.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $115.86m | $106.76m | - | - | 0.00% | 0.00% |
| June 30, 2024 | $114.43m | $112.73m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $96.84m | $101.5m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Veracyte Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.